{"prompt": "['Aimmune Therapeutics, Inc.', 'AR101', 'ARC009 Protocol Amend 1.0', '11 Apr 2018 - FINAL', 'Aimmune Confidential Information', 'Page 118 of 122', '[23] For all females of childbearing potential.', 'ACT, Asthma Control Test; C-ACT, Childhood Asthma Control Test; ED, early discontinuation; EQ-5D, European Quality of Life 5-Dimensions health', 'questionnaire; EQ-5D-5L, EQ-5D 5-Levels; EQ-5D-Y, EQ-5D Youth; FAIM, Food Allergy Independent Measure; FAIM-CF, FAIM - child form; FAIM-PF,', 'FAIM - parent form; FAIM-PFT, FAIM - parent form teenager; FAIM-TF, FAIM - teenager form; FAQL-PB, Food Allergy Quality of Life - Parental Burden;', 'FAQLQ, Food Allergy Quality of Life Questionnaire; FAQLQ-CF, FAQLQ - child form; FAQLQ-PF, FAQLQ - parent form; FAQLQ-PFT, FAQLQ - parent', 'form teenager; FAQLQ-TF, FAQLQ - teenager form; FEV1, forced expiratory volume in the first second of expiration; GI, gastrointestinal; HADS, Hospital', 'Anxiety and Depression Scale; HRQOL, health-related quality of life; na, not applicable; NHLBI, National Heart, Lung, and Blood Institute; OLFC,', 'open-label food challenge; PEESS v2.0, Pediatric Eosinophilic Esophagitis Symptom Scores version 2.0; PEFR, peak expiratory flow rate; RWPC, real-world', 'peanut challenge; SCORAD, scoring atopic dermatitis; TNSS, Total Nasal Symptom Score; TSQM-9, Treatment Satisfaction Questionnaire for Medication;', 'unsched, unscheduled.']['Aimmune Therapeutics, Inc.', 'AR101', 'ARC009 Protocol Amend 1.0', '11 Apr 2018 - FINAL', 'Aimmune Confidential Information', 'Page 119 of 122', 'Appendix 6: Study Schedule of Activities for Standard of Care Alone', 'Study Visit (Week)', '1', '14', '27', '40', 'OLFC / 53', '66', 'Unsched [1]', 'Early Disc [2]', 'Exit / 79 [2]', 'Window (Days)', 'na', '7', 'na', 'na', '7', 'HRQOL Questionnaires and Bespoke Questions [3]', 'EQ-5D [4]', 'X', 'X', 'X', 'X', 'X [4]', 'X', 'X', 'X', 'FAQL-PB [5]', 'X', 'X', 'X', 'X', 'HADS [5]', 'X', 'X', 'X', 'FAQLQ, FAIM [6]', 'X', 'X [6]', 'X', 'X', 'X', 'Bespoke global assessment of HRQOL', 'X', 'X', 'X', 'Bespoke assessment of control and confidence', 'X', 'X', 'X', 'Assessment of food challenge outcomes', 'X', 'Randomization [7]', 'X', 'General Activities', 'Weight, height', 'X', 'X', 'X', 'X', 'X', 'X', 'X', 'X', 'X', 'Vital signs (blood pressure, heart rate, temperature)', 'X', 'X', 'X', 'X', 'X', 'X', 'ACT/C-ACT, SCORAD, TNSS (if completed at screening)', 'X', 'X', 'X (optional)', 'X', 'X', 'PEFR [8]', 'X', 'X', 'X', 'X (optional)', 'X', 'X', 'Asthma evaluation [9]', 'X', 'X', 'X (optional)', 'X', 'X', 'Symptom-directed physical examination [10]', 'X', 'X', 'X', 'Complete physical examination [10]', 'X', 'X (optional)', 'X', 'X', 'Diet/food allergen exposure review', 'X', 'X', 'X', 'X', 'X', 'X', 'Food allergy instruction [11]', 'X', 'X', 'X (optional)', 'X', 'X', 'Contraception review', 'X', 'X', 'X (optional)', 'Adverse events review [12]', 'X', 'X', 'X', 'X', 'X', 'Concomitant medications review & instruction [13]', 'X', 'X', 'X', 'X', 'X', 'Skin prick test to peanut extract', 'X [14]', 'OLFC', 'X [15]', 'Laboratory Evaluations [16]', 'Urine pregnancy test [17]', 'X', 'X [14]', 'X (optional)', 'X', 'X', 'Blood sample for basophil activation test (BAT)', 'X [14]', 'X', 'X']\n\n###\n\n", "completion": "END"}